Medicine and Dentistry
Therapeutic Procedure
100%
Patient
100%
Vascular Disease
100%
Clopidogrel
100%
Observation
28%
Incidence
14%
Vascularity
14%
Apoplexy
14%
Myocardial Infarction
14%
Cerebrovascular Disease
14%
Amaurosis
14%
Coronary Artery
14%
Randomized Clinical Trial
14%
Percutaneous Coronary Intervention
14%
Intention-to-Treat Analysis
14%
Arteriosclerosis Obliterans
14%
Subgroup Analysis
14%
Relative Risk Reduction
14%
Atherosclerosis
14%
Death
14%
Placebo
14%
Nursing and Health Professions
Patient
100%
Clopidogrel
100%
Vascular Disease
100%
Confidence Interval
28%
Observation
28%
Blindness
14%
Protection
14%
Long Term Care
14%
Heart Infarction
14%
Peripheral Occlusive Artery Disease
14%
Intention to Treat Analysis
14%
Percutaneous Coronary Intervention
14%
Analysis
14%
Atherosclerosis
14%
Sample
14%
Death
14%
Incidence
14%
Placebo
14%
Cerebrovascular Disease
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clopidogrel
100%
Vascular Disease
100%
Randomized Clinical Trial
16%
Atherosclerosis
16%
Heart Infarction
16%
Incidence
16%
Death
16%
Placebo
16%
Blindness
16%
Peripheral Occlusive Artery Disease
16%
Cerebrovascular Disease
16%
Neuroscience
Vascular Disease
100%
Clopidogrel
100%
Stroke
16%
Intention
16%
Myocardial Infarction
16%
Cerebrovascular Disease
16%
Placebo
16%
Biochemistry, Genetics and Molecular Biology
Clopidogrel
100%
Reduction (Chemistry)
33%
Vascularization
16%
Randomized Clinical Trial
16%
Incidence
16%
Sample
16%
Risk Reduction
16%